Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Birmingham Research and Development Ltd (BRDL) is the commercial exploitation and technology transfer company for the University of Birmingham. The company is responsible for identifying, protecting, and commercializing intellectual property generated by the university's research, particularly in the life sciences, healthcare, and engineering sectors. BRDL facilitates the creation of spin-out companies, manages patent portfolios, and establishes licensing agreements with industrial partners. By bridging the gap between academic research and commercial application, BRDL plays a critical role in bringing innovative medical technologies and therapeutic discoveries to the market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BRDL.